Autopsy report · NCT04172363

Clinical Relevance of the Antimicrobial Resistance Testing in the Treatment of Chronic Wounds With Antiseptics

“PI left site”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 3

Sponsor

RWTH Aachen University

Sponsor type

University, hospital or other

Conditions

Decubiti; Chronic Wounds; Acute Wounds

Interventions

Octenisept and Serasept

Participants

0

Sites

1

Countries

Germany

Trials that died the same way

• Hydroxychloroquine in Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Hormonal Therapy
  “PI Leaving Site” (89% match in meaning)
• Analysis of Cardiac Biomarker Racial Discrepancies
  “PI no longer with the site” (77% match in meaning)
• Mechanical Ventilation in Severe Brain Injury: The Effect of Positive End Expiratory Pressure on Intracranial Pressure
  “Departure of PI” (65% match in meaning)
• Brain Autoregulation Research Study
  “PI departure” (63% match in meaning)
• A Strategy to Improve Implementation of LTVV for Patients w/ ARDS
  “PI left institution” (63% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.